Frank Rimerman Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
20,680
+10,826
| +110% | +$757K | 0.1% | 156 |
|
|
2025
Q1 | $724K | Sell |
9,854
-2,894
| -23% | -$213K | 0.06% | 246 |
|
|
2024
Q4 | $835K | Buy |
12,748
+2,992
| +31% | +$196K | 0.06% | 221 |
|
|
2024
Q3 | $760K | Sell |
9,756
-38
| -0.4% | -$2.96K | 0.05% | 261 |
|
|
2024
Q2 | $764K | Buy |
9,794
+9,756
| +25,674% | +$761K | 0.05% | 263 |
|
|
2024
Q1 | $2.58K | Buy |
38
+10
| +36% | +$678 | ﹤0.01% | 264 |
|
|
2023
Q4 | $1.89K | Buy |
+28
| New | +$1.89K | ﹤0.01% | 269 |
|